Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vascular Surgery

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 37 articles:
HTML format



Single Articles


    July 2022
  1. KHATRI P
    Intravenous thrombolysis before thrombectomy for acute ischaemic stroke.
    Lancet. 2022;400:76-78.
    PubMed    


  2. MITCHELL PJ, Yan B, Churilov L, Dowling RJ, et al
    Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial.
    Lancet. 2022;400:116-125.
    PubMed     Abstract available


  3. FISCHER U, Kaesmacher J, Strbian D, Eker O, et al
    Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
    Lancet. 2022;400:104-115.
    PubMed     Abstract available


    March 2022
  4. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis? - Authors' reply.
    Lancet. 2022;399:1116.
    PubMed    


  5. ABBOTT AL, Wijeratne T, Zeebregts CJ, Ricco JB, et al
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
    Lancet. 2022;399:1115-1116.
    PubMed    


  6. KAMTCHUM-TATUENE J, Jickling GC
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
    Lancet. 2022;399:1114-1115.
    PubMed    


    February 2022
  7. ALMEKHLAFI MA, Coutts SB
    Anti-thrombotics cause harm in the setting of stroke thrombectomy.
    Lancet. 2022 Feb 28. pii: S0140-6736(22)00335.
    PubMed    


  8. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
    What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Lancet. 2022;399:691-694.
    PubMed    


    November 2021
  9. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
    PubMed    


  10. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.
    PubMed    


  11. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    PubMed     Abstract available


  12. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    PubMed     Abstract available


  13. JOVIN TG, Nogueira RG, Lansberg MG, Demchuk AM, et al
    Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)01341.
    PubMed     Abstract available


  14. DIPPEL D, Roozenbeek B
    Late thrombectomy for ischaemic stroke.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02097.
    PubMed    


  15. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    PubMed    


  16. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    PubMed    


  17. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    PubMed     Abstract available


    October 2021
  18. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    PubMed     Abstract available


    September 2021
  19. TULAMO R, Venermo M
    Intervention for asymptomatic carotid artery stenosis.
    Lancet. 2021;398:1025-1027.
    PubMed    


    August 2021
  20. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
    Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.
    Lancet. 2021 Aug 27. pii: S0140-6736(21)01910.
    PubMed     Abstract available


    July 2021
  21. MOSS JG, Wu O, Bodenham AR, Agarwal R, et al
    Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
    Lancet. 2021;398:403-415.
    PubMed     Abstract available


  22. TAXBRO K, Chopra V
    Appropriate vascular access for patients with cancer.
    Lancet. 2021;398:367-368.
    PubMed    


    May 2021
  23. KOO BK, Kang J, Park KW, Rhee TM, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)01063.
    PubMed     Abstract available


  24. AZIZI M, Sanghvi K, Saxena M, Gosse P, et al
    Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00788.
    PubMed     Abstract available


    April 2021
  25. GALLI M, Benenati S, Capodanno D, Franchi F, et al
    Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2021;397:1470-1483.
    PubMed     Abstract available


  26. SIBBING D, Kastrati A
    Guided P2Y12 inhibitor therapy after percutaneous coronary intervention.
    Lancet. 2021;397:1423-1425.
    PubMed    


  27. RICKARD CM, Marsh NM, Larsen EN, McGrail MR, et al
    Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial.
    Lancet. 2021;397:1447-1458.
    PubMed     Abstract available


    March 2021
  28. LONNEBAKKEN MT
    The risk of no risk in STEMI.
    Lancet. 2021;397:1039-1040.
    PubMed    


  29. FIGTREE GA, Vernon ST, Hadziosmanovic N, Sundstrom J, et al
    Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Lancet. 2021;397:1085-1094.
    PubMed     Abstract available


    November 2020
  30. SILVAIN J, Lattuca B, Beygui F, Range G, et al
    Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32236.
    PubMed     Abstract available


    October 2020
  31. JEGER RV, Farah A, Ohlow MA, Mangner N, et al
    Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32173.
    PubMed     Abstract available


  32. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNT
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32114.
    PubMed     Abstract available


    August 2020
  33. FERRARI R, Ford I, Fox K, Challeton JP, et al
    Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31790.
    PubMed     Abstract available


  34. KIM HS, Kang J, Hwang D, Han JK, et al
    Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31791.
    PubMed     Abstract available


    July 2020
  35. CHI G, Marszalek J
    Differential effect of ticagrelor on irreversible harms in diabetes.
    Lancet. 2020;396:93.
    PubMed    


  36. CAMPBELL BCV, Khatri P
    Stroke.
    Lancet. 2020;396:129-142.
    PubMed     Abstract available


    April 2020
  37. THE LANCET
    Open versus endovascular repair of aortic aneurysms.
    Lancet. 2020;395:1090.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: